Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan 8;56(2):458-460.
doi: 10.1016/j.tetlet.2014.11.126.

Facile syntheses of functionalized toll-like receptor 7 agonists

Affiliations

Facile syntheses of functionalized toll-like receptor 7 agonists

Babatope Akinbobuyi et al. Tetrahedron Lett. .

Abstract

Protein conjugates of toll-like receptor 7 agonists have been shown to elicit powerful immune responses. In order to facilitate our studies in this area our group has developed efficient syntheses for a number of functionalized derivatives that retain immune stimulatory activity.

Keywords: Adenine derivatives; Immune activation; Toll-like receptor; Vaccines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Synthetic TLR-7 agonists
Scheme 1
Scheme 1
Reagents and conditions: i. ArCH2Br, K2CO3, DMSO, rt, ii. n-BuONa/n-BuOH, reflux, iii. n-BuONa/n-BuOH, reflux, then add H2O, reflux, iv. Br2, CH2Cl2, rt 12 h or Br2, AcOH, AcONa, rt, 1 h.
Scheme 2
Scheme 2
Reagents and conditions: NaOH, CH3OH, reflux.
Scheme 3
Scheme 3
Reagents and conditions: i. CH3ONa, CH3OH, reflux, 61%, ii. HCl (conc), 43%, iii. HCl (conc), 15%.
Scheme 4
Scheme 4
Reagents and conditions: i. CH3ONa, CH3OH, reflux, 86%, ii. Pd(PPh3)2Cl2, CuI, Et3N, then propargyl alcohol, reflux, iii. NaI, TMSCl, CH3CN, reflux, iv. Pd(PPh3)2Cl2, CuI, Et3N, then BOC-propargyl amine, reflux, v. Pd/C, H2, MeOH, rt
Scheme 5
Scheme 5
Reagents and conditions: i. BOC-ethylenediamine, DIPEA, COMU, DMSO, DCM, 0°-rt, 2 h, ii. TFA, DCM, rt, 1 h, iii. BOC-NH-CH2CH2OCH2CH2OCH2CH2-NH2, DIPEA, COMU, DMSO, DCM, 0°-rt, 2 h.

Similar articles

Cited by

References

    1. Medzhitov R, Janeway CA., Jr Cell. 1997;91:295–298. - PubMed
    1. Takeda K, Akira S. Int Immunol. 2005;17:1–14. - PubMed
    1. Aderem A, Ulevitch RJ. Nature. 2000;406:782–787. - PubMed
    1. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. Eur J Immunol. 2001;31:3388. - PubMed
    1. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo H, Hoshino K, Horiuchi T, Tomizawa H, Takeda K, Akira S. Nat Immunol. 2002;3:196–200. - PubMed